Jodi Barrientos on Leading Synthetic Biology’s Next Wave

Overview

• Post By : Kumar Jeetendra


• Source: Microbioz India


• Date: 06 Oct,2025

Microbioz India recently hosted a podcast in which Jodi Barrientos, CEO of Ribbon Bio, very eloquently described her career path, her thoughts on the future of synthetic bio, and the change(s) she hopes to implement in our industry.

Jodi Barrientos spent 17 years in the commercial sector, exceeding the expectations of some of the world’s top companies in advancing the strategic commercial goals and the operational performance of those companies, including organizational restructuring and digital transformations. Her career journey is unique, spanning a bench-scientist position to the top of the corporate hierarchy – executive commercial leader, demonstrating the interplay of science and business value to the life science industry.

Listen to the full podcast now on Microbioz India Newsstand.

In the podcast, Jodi communicates the innovation priorities for Ribbon Bio and her plans to keep the company at the cutting edge of synthetic biology to address the fast shifting demands of the market. She describes the need for sustainable business model innovation, building resilient organizations, and addressing the business paradigm shifts prevalent in emerging economies.

Her, now symbolic, ability to drive change and commercial execution have been noted. Jodi’s comments also speak to the need for change in operational structures in biopharma commercially and ideationally, through digitization and collaborative frameworks. Jodi’s thoughts on future operational models and structures in the biopharma world speak to the extent of change her industry needs.

This dialogue highlights her journey in leadership and the remarkable possibilities synthetic biology offers in the future of healthcare, pharmaceuticals, and the life sciences.